Class Information
*This course has reached capacity and is now closed*
Course Objectives
1) Describe current STD/HIV screening strategies and diagnostic algorithms.
2) Describe current STD/HIV treatment recommendations.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses and Licensed Practical Nurses
**Priority is given to medical providers who have not previously attended a PTC STD Intensive Course in Indiana. Non-clinical professionals and those who attended in the past will be automatically placed on the waitlist. **
Registration
Online registration is required. Space is limited. If you are a new user, please use a valid email address to create an account. Returning users may login with their email and password. If you forgot your password, click on the "Forgot Password" link below the login fields.
Please note: your registration is not complete until you receive a confirmation email from domain @cumc.columbia.edu (allow 1-2 days after you register). All course correspondence will be sent via email.
Continuing Education SC2855
ACCREDITATION STATEMENTS:
CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control & Prevention and New York City Sexually Transmitted Diseases Prevention Training Center. The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 6.0 contact hours.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Bree Weaver and she wishes to disclose that her spouse owns stock in Johnson & Johnson and Pfizer, and that she has been a member of the Gilead Advisory Board since May 2019.
Planning committee reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
The Centers for Disease Control and Prevention and New York City Sexually Transmitted Diseases Prevention Training Center are jointly providing the CNE for this activity.
CDC did not accept commercial support for this continuing education activity.